Prior Authorization and Prior Authorization Code List
Customize your policy alerts
Sign up for all Baylor Scott & White Health Plan policy alerts
Know when Baylor Scott & White Health Plan releases new policies or updates existing guidance.
Monitor payer policy activity
Governs Baylor Scott & White Health Plan prior authorization requirements, lists CPT procedure codes that require prior authorization or are on the prior authorization list, and explains verification and portal submission instructions for providers and members.
No material clinical or coverage changes in this revision.
Coverage Criteria Summary
Coverage stance summary
Coverage and prior authorization stance described in this part:
Coding listing — informational only
No explicit coverage criteria in this excerpt; items are code descriptions and effective/mapping dates.
Code listings (informational)
Code equivalency listings present in this section
Panel composition requirements
Panel composition and analysis modality requirements (examples pulled from listed codes):
Examples
Specimen and analysis modality
Specimen and analysis modality notes:
Reported analytes/modality examples
- Some solid organ neoplasm panels permit DNA analysis or combined DNA and RNA analysis and may report copy number variants, microsatellite instability, tumor mutation burden, and rearrangements (eg, 81455–81459, 81462–81464).
- Cell-free (plasma) panels are explicitly indicated for some codes (eg, 81462–81464) and may include DNA or combined DNA/RNA interrogation.
Listed codes
Code listings and effective/reference dates
Descriptive listings only
Descriptive code entries and test characteristics in this section (no explicit coverage criteria provided here).
Coding reference (no coverage criteria present in these chunks)
This excerpt provides code descriptors and effective/activation dates; it does not state coverage determinations or medical necessity criteria for the listed codes within these chunks.
Code Lists and Coding Notes
| 00170 | Anesthesia for intraoral procedures, including biopsy; not otherwise specified. |
| 11950 | Subcutaneous injection of filling material (eg, collagen); 1 cc or less. |
| 11951 | Subcutaneous injection of filling material (eg, collagen); 1.1 to 5.0 cc. |
| 11952 | Subcutaneous injection of filling material (eg, collagen); 5.1 to 10.0 cc. |
| 11954 | Subcutaneous injection of filling material (eg, collagen); over 10.0 cc. |
| 14041 | Adjacent tissue transfer or rearrangement; defect 10.1 sq cm to 30.0 sq cm. |
| 14301 | Adjacent tissue transfer or rearrangement; defect 30.1 sq cm to 60.0 sq cm. |
| 15100 | Split-thickness autograft, trunk, arms, legs; first 100 sq cm or less. |
| 15200 | Full thickness graft, free, including direct closure of donor site, trunk; 20 sq cm or less. |
| 15771 | Grafting of autologous fat harvested by liposuction technique; 50 cc or less injectate. |
| 22586 | Arthrodesis, pre-sacral interbody technique, includes bone graft when performed, L5-S1 interspace. |
| 22600 | Arthrodesis, posterior or posterolateral technique, single interspace; cervical below C2. |
| 22612 | Arthrodesis, posterior or posterolateral technique, single interspace; lumbar (with lateral transverse technique when performed). |
| 22630 | Arthrodesis, posterior interbody technique, single interspace, lumbar. |
| 22632 | Arthrodesis, posterior interbody technique, lumbar; each additional interspace. |
| 22854 | Insertion of intervertebral biomechanical device(s) with integral anterior instrumentation to disc space in conjunction with interbody arthrodesis, each interspace. |
| 22856 | Insertion of intervertebral biomechanical device(s) in conjunction with interbody arthrodesis; total disc arthroplasty, cervical single interspace. |
| 22859 | Insertion of intervertebral biomechanical device(s) to disc space or vertebral body defect without interbody arthrodesis. |
| 22861 | Revision including replacement of total disc arthroplasty, anterior approach, single interspace; cervical. |
| 22899 | Unlisted procedure, spine. |
| 29805 | Arthroscopy, shoulder, diagnostic, with or without synovial biopsy. |
| 29826 | Arthroscopy, shoulder, decompression of subacromial space with partial acromioplasty. |
| 29861 | Arthroscopy, hip, surgical; with removal of loose body or foreign body. |
| 29880 | Arthroscopy, hip, with meniscectomy including chondroplasty. |
| 29876-29883, 29884-29889 | Arthroscopy (hip vs knee) procedures with synovectomy and various associated procedures mapped/equated |
| 29914-29916 | Arthroscopy, hip, with femoroplasty, acetabuloplasty, labral repair |
| 30400-30469 | Rhinoplasty primary and secondary, repairs, nasal valve procedures |
| 32851-32854, 32994 | Lung transplant and pulmonary tumor ablation procedures |
| 33267-33269, 33274, 33289 | Left atrial appendage exclusion and leadless pacemaker/transcatheter monitors |
| 33340, 33361-33366, 33418, 33477 | Transcatheter valve and related cardiac procedures (TAVR, mitral repair, pulmonary valve) |
| 33927-33935, 33945 | Heart and heart-lung transplant; artificial heart implantation |
| 36465-36483, 36836-36837 | Vein and endovenous ablation, sclerotherapy, mechanochemical and cyanoacrylate procedures; percutaneous AV fistula creation |
| 43290-43291, 43644-43659, 43770-43775, 43845-43848 | Endoscopic bariatric balloon procedures and various laparoscopic/open bariatric/gastric restrictive procedures |
| 63047 | Laminectomy, facetectomy and foraminotomy; single vertebral segment (thoracic/lumbar) — decompression of spinal cord/nerve roots |
| 63048 | Each additional vertebral segment (List separately in addition to primary procedure) |
| 63050 | Laminoplasty, cervical, with decompression, 2 or more vertebral segments |
| 63650 | Percutaneous implantation of neurostimulator electrode array, epidural |
| 63685 | Insertion/replacement of spinal neurostimulator pulse generator requiring pocket creation |
| 64479 | Transforaminal epidural injection with imaging guidance, cervical or thoracic, single level |
| 64483 | Transforaminal epidural injection with imaging guidance, lumbar or sacral, single level |
| 64628 | Thermal destruction of intraosseous basivertebral nerve; first 2 vertebral bodies |
| 67900 | Repair of brow ptosis (supraciliary, mid-forehead or coronal approach) |
| 70450 | CT head or brain; without contrast material |
| 71550 | CT angiography, chest (noncoronary), with contrast = MRI chest without contrast (evaluation of hilar and mediastinal lymphadenopathy) |
| 71551 | CT angiography, chest with contrast = MRI chest with contrast |
| 71552 | CT angiography, chest without then with contrast = MRI chest without then with contrast and further sequences |
| 74150-74178 series | CT abdomen/pelvis and CTA abdomen/pelvis codes and their MRI/MRA equivalents and related CT codes |
| 75571-75577 series | Cardiac CT/MRI codes including coronary calcium scoring and CTA coronary with dates |
| 77261-77499 series | Therapeutic radiology planning, simulation, dosimetry, brachytherapy, and SBRT delivery and management codes |
| 77387 | Stereotactic body radiation therapy, treatment delivery, per fraction (includes image guidance) |
| 77435 | Stereotactic body radiation therapy, treatment management, per treatment course (entire course not to exceed 5 fractions) |
| 77469 | SBRT treatment delivery, per fraction to 1 or more lesions (entire course not to exceed 5 fractions) |
| 77470 | SBRT treatment delivery, per fraction to 1 or more lesions (entire course not to exceed 5 fractions) |
| 77499 | Unlisted procedure, therapeutic radiology treatment management (SBRT related) |
| 77520 | Proton treatment delivery; simple |
| 77522 | Proton treatment delivery; simple, with compensation |
| 77523 | Proton treatment delivery; intermediate |
| 77525 | Proton treatment delivery; complex |
| 77761 | Intracavitary radiation source application; simple (infusion/instillation of radioelement solution) |
| 77762 | Intracavitary radiation source application; intermediate |
| 77763 | Intracavitary radiation source application; complex |
| 77767 | Remote afterloading HDR radionuclide skin surface brachytherapy; lesion diameter up to 2.0 cm or 1 channel |
| 77768 | Remote afterloading HDR radionuclide skin surface brachytherapy; lesion diameter over 2.0 cm and 2+ channels |
| 77770 | Remote afterloading HDR radionuclide interstitial or intracavitary brachytherapy; 1 channel |
| 77771 | Remote afterloading HDR radionuclide interstitial or intracavitary brachytherapy; 2-12 channels |
| 77772 | Remote afterloading HDR radionuclide interstitial or intracavitary brachytherapy; over 12 channels |
| 77778 | Interstitial radiation source application, complex |
| 77789 | Surface application of low dose rate radionuclide source |
| 78012 | Thyroid uptake, single or multiple quantitative measurement(s) |
| 78013 | Thyroid imaging (including vascular flow) |
| 78014 | Thyroid imaging with single or multiple uptake quantitative measurement(s) |
| 78070 | Parathyroid planar imaging |
| 78451 | Myocardial perfusion imaging, tomographic (SPECT); single study |
| 78431 | Myocardial imaging, PET, perfusion study with CT transmission; multiple studies |
| 78491 | Myocardial imaging, PET, perfusion study; single study |
| 78811 | PET imaging; limited area |
| 78812 | PET imaging; skull base to mid-thigh |
| 78813 | PET imaging; whole body |
| 80145 | Adalimumab (listed in molecular/genetic section) |
| 81161 | DMD (dystrophin) deletion and duplication analysis |
| 81162 | BRCA1/BRCA2 full sequence and duplication/deletion analysis |
| 81163 | BRCA1/BRCA2 full sequence analysis |
| 81164 | BRCA1/BRCA2 full duplication/deletion analysis |
| 81175 | ASXL1 full gene sequence |
| 81194 | NTRK translocation analysis |
| 81210 | BRAF gene analysis, V600 variant(s) |
| 81212 | BRCA1/BRCA2 specific variant panel (185delAG, 5385insC, 6174delT) |
| 81220 | CFTR common variants analysis |
| 81243 | F9 / FMR1 related descriptors: F9 full gene sequence = FMR1 evaluation to detect abnormal (expanded) alleles |
| 81244 | FMR1 characterization of alleles (expanded size and promoter methylation status) |
| 81301 | Microsatellite instability analysis of markers for mismatch repair deficiency |
| 81302 | MECP2 full sequence analysis |
| 81307 | PALB2 full gene sequence |
| 81407 | Molecular pathology procedure, Level 8 (analysis of 26-50 exons or multiple genes) |
| 81408 | Molecular pathology procedure, Level 9 (>50 exons in single gene) |
| 81410 | Aortic dysfunction/dilation panel — must include at least 9 named genes |
| 81418 | Pharmacogenomics genomic sequence analysis panel — must include at least 6 genes including CYP2C19 and CYP2D6 |
| 81430 | Hearing loss genomic panel — must include sequencing of at least 60 genes |
| 81439 | Hereditary cardiomyopathy panel — must include sequencing of at least 5 cardiomyopathy-related genes |
| 81443 | Various newborn/diagnostic panels and solid organ neoplasm panels (5-50 genes) |
| 81445 | Solid organ neoplasm genomic panel, 5-50 genes, DNA or combined DNA/RNA |
| 81450 | Hematolymphoid neoplasm genomic panel, 5-50 genes, DNA or combined DNA/RNA |
| 81455 | Solid organ or hematolymphoid neoplasm panel, 51+ genes, DNA or combined DNA/RNA |
| 81493 | mRNA gene expression profiling (23 genes) reported as risk score |
| 81503 | Oncology (ovarian) biochemical assay algorithm (five proteins) risk score |
| 81504 | Tissue of origin microarray gene expression profiling (>2,000 genes) |
| 81518 | Oncology (breast) mRNA gene expression profiling (11 genes) reported as risk/benefit scores |
| 81520 | Oncology (breast) 21-gene RT-PCR recurrence score (and variants / crosswalked codes and updates) |
| 88269 | Chromosome analysis (amniotic fluid or chorionic villus) example mapping to other procedure descriptions |
| 91110 | Cross-referenced gastrointestinal tract imaging (capsule endoscopy) mapping |
| 93451 | Right heart catheterization mapping referenced alongside chromosome analysis code |
| 93460 | Catheter placement coronary angiography with right and left heart catheterization mapping |
| 93455-93461 | Catheter placement in coronary artery(s) for coronary angiography and related left/right heart catheterization and graft angiography as described in each code entry. |
| 93590-93597 | Percutaneous transcatheter closure procedures and congenital heart defect catheterizations with imaging guidance as described per code. |
| 0003U-0118U | Proprietary/unlisted laboratory and algorithm-based test codes (U-codes and some T-codes) with specific test names and brief descriptions |
| 0180U–0190U | Series of red cell antigen genotyping codes (ABO, Colton, Cromer, Diego, etc.) with gene/exon targets |
| 0257U | VLCAD leukocyte enzyme activity, whole blood |
| 0258U | Autoimmune (psoriasis), mRNA, NGS gene expression profiling 50-100 genes, skin-surface adhesive patch, algorithm likelihood of response to biologics |
| 0259U | Nephrology (CKD), NMR spectroscopy myo-inositol, valine, creatinine combined with cystatin C to determine eGFR, serum |
| 0261U | Oncology (colorectal), AI image analysis of histologic/IHC features, immune response and recurrence-risk score |
| 0329T | Monitoring of intraocular pressure for 24 hours or longer, with interpretation and report |
| 0329U | Oncology (neoplasia), exome and transcriptome sequence analysis with tumor/normal subtraction and therapy associations |
| 0332U | Oncology (pan-tumor), genetic profiling of 8 epigenetic markers by qPCR |
| 0340U | Oncology (pan-cancer), MRD analysis from plasma personalized to patient based on prior NGS |
| 0355U | APOL1 risk variants (G1, G2) testing |
| 0364U | Oncology (hematolymphoid), genomic sequence analysis (multiplex PCR/NGS) with MRD quantification |
| 0362U | Gene-expression profiling via targeted hybrid capture-enrichment RNA sequencing (thyroid cancer context) - 82 content genes + 10 housekeeping genes |
| 0363U | Evaluation of 17 DNA biomarkers using droplet digital PCR (ddPCR), cell-free DNA; algorithm reported as prognostic risk score |
| 0364U | Genomic sequence analysis using multiplex PCR and NGS with algorithm quantifying dominant clonal sequence(s) for MRD |
| 0588T | Integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generator |
| 0589T | Electronic analysis with simple programming of implanted integrated neurostimulation system for bladder dysfunction, posterior tibial nerve, 1-3 parameters |
| 0590T | Electronic analysis with complex programming of implanted integrated neurostimulation system for bladder dysfunction, posterior tibial nerve, 4 or more parameters |
| 0591T | Health and well-being coaching face-to-face; individual, initial assessment |
| 0592T | Health and well-being coaching face-to-face; individual, follow-up session, at least 30 minutes |
| 0593T | Health and well-being coaching face-to-face; group (2 or more individuals), at least 30 minutes |
| 0704T | Remote treatment of amblyopia using an eye tracking device; device supply with initial set-up and patient education on use of equipment. |
| 0705T | Remote treatment of amblyopia using an eye tracking device; surveillance center technical support including data transmission with analysis, with a minimum of 18 training hours, each 30 days. |
| A4238 | Supply allowance for adjunctive, nonimplanted continuous glucose monitor (CGM), includes all supplies and accessories, 1 month supply = 1 unit of service. |
| C1747 | Endoscope, single-use (i.e., disposable), urinary tract, imaging/illumination device (insertable). |
| C2624 | Implantable wireless pulmonary artery pressure sensor with delivery catheter, including all system components. |
Provider Actions, Prior Authorization & Submission
Submit prior authorization via secure portal; authorization not a payment guarantee
Prior Authorization is not a guarantee of benefits or payment at the time of service; reimbursement of authorized services depends on member eligibility and benefit limitations/exclusions. Registered users may submit electronic preauthorization requests via the secure provider portal; call the number on the member's ID card for portal information. Newly published or emerging codes/therapies may require prior authorization—check with Baylor Scott & White Health Plan before providing these services.
- Prior authorization does not guarantee payment; benefits determined by member's plan and eligibility at time of service.
- Submit preauthorization electronically using the secure provider portal (registered users).
- Contact the number on the member ID card or Provider Relations Representative for assistance.
- Newly published or emerging codes/therapies may require prior authorization—verify with the plan prior to service.
Verify member benefits and contact customer service/portal
Verify member benefits and coverage before providing services by consulting the member benefit booklet or contacting customer service using the number on the member's ID card.
- Check member eligibility, benefit limitations/exclusions, and evidence of coverage provisions prior to service.
- Call the customer service number printed on the member's ID card for portal and coverage information.
Use listed CPT codes for spine arthrodesis and instrumentation
When billing spine arthrodesis or spinal instrumentation, use the listed CPT arthrodesis and instrumentation codes (examples shown) exactly as described in the code list.
Bill interbody device procedures with the listed CPT codes
For interbody device procedures (insertion, revision, removal), bill using the specified interbody device CPT codes as listed in the policy.
Report major joint arthroplasty with specified CPT codes
Major joint arthroplasty procedures must be reported with the listed arthroplasty CPT codes from the policy.
Use listed arthroscopy CPT codes for shoulder, hip, knee
Arthroscopy procedures for shoulder, hip, and knee must be billed with the arthroscopy CPT codes shown in the code list.
- Examples include shoulder arthroscopy codes 29805–29828 and hip/knee arthroscopy codes 29860–29889 and 29914–29916.
- Use mappings noted in the policy where hip arthroscopy descriptors are equated to knee arthroscopy descriptors for coding reference.
Apply orthopedics CPT code mappings and effective dates
Follow the CPT code mappings and effective dates provided for orthopedic arthroscopy and related procedures when selecting codes.
- Mapping examples listed include ranges 29876–29883, 29884–29889 and 29914–29916; adhere to the descriptors and effective date annotations in the policy.
Bill rhinoplasty/ENT procedures with listed CPT codes
Use the specified rhinoplasty/ENT CPT codes shown in the listing when billing nasal reconstruction or rhinoplasty services.
- Rhinoplasty code range examples include 30400–30469; follow listed descriptors and referenced dates.
Use listed CPT codes for cardiac and transcatheter procedures
Report high‑acuity cardiac and transcatheter procedures using the CPT codes and descriptors listed in the policy.
Refer to the partial CPT procedure code list when billing
When billing the partial CPT list provided, use the exact CPT procedure codes and descriptors shown in the policy excerpt.
Code listing provided for reference; check portal for authorization requirements
The code listings in chunk 72 and neighboring sections enumerate CPT codes with descriptors but do not include explicit prior authorization rules—treat these as informational coding references and verify authorization requirements separately.
- Examples in this window include 63047–63057 and related spine/neuro codes.
- Check the plan's prior authorization portal for which codes require authorization despite being listed here.
Use code equivalencies and effective dates for coding crosswalks
Code equivalencies and effective dates shown in the policy (e.g., CTA chest codes mapped to MRI equivalents) are informational; use the exact code mappings and effective date annotations when selecting codes for billing or crosswalks.
- Examples: 71550–71552 CTA chest mappings to MRI chest codes; effective date annotations are provided alongside each mapping.
- No explicit prior authorization action is stated in this equivalency section—verify authorization separately.
Bill radiation therapy/SBRT with listed CPT codes and course limits
Radiation therapy and SBRT procedures should be billed with the listed therapeutic radiology CPT codes and note the policy’s course/fraction guidance.
Use listed CPT codes for brachytherapy and radioelement infusions (follow descriptor notes)
Brachytherapy and radioelement infusion procedures must be reported using the listed CPT codes and descriptors; note that many entries include follow-up care in the descriptor language.
- Example codes include 77761–77763, 77767–77772, 77778, 77789–77799.
- Descriptors often state that infusion/instillation includes 3-month follow-up care—follow descriptors when documenting and billing.
Bill PET and radiopharmaceutical localization with listed CPT codes
PET and radiopharmaceutical localization services must be billed with the CPT codes and descriptors listed for nuclear medicine and PET procedures.
- Examples include radiopharmaceutical localization codes 78800–78804 and PET codes 78811–78816.
- Use the policy’s descriptors and effective dates when reporting these services.
Ensure genomic panels meet the policy's minimum gene-count and composition requirements
Genomic sequence analysis panels must meet panel composition and minimum gene-count requirements specified by code when applicable (examples provided in the policy).
- Example: hearing loss panel code 81430 must include sequencing of at least 60 genes.
- Example: certain Noonan spectrum panels must include at least 12 genes; other panels may require a minimum of 5 genes as specified.
Report cardiovascular procedures with listed CPT codes and effective dates
Use the listed cardiovascular CPT codes for cardiology procedures and catheterization services as provided in the policy, observing the effective date annotations.
- Cardiology code examples include 93455–93461 and related left/right heart catheterization codes.
- Follow the effective date (May 01, 2026) and any per-code date annotations when billing.
Bill proprietary laboratory/tests with listed U-/T-/M-codes and follow specimen notes
Proprietary laboratory and algorithmic test services must be billed using the U-/T-/M-codes listed in the policy and with the specified test descriptors and specimen notes.
- The policy enumerates multiple U-codes (e.g., 0003U–0118U, 0037U, 0105U–0111U) with brief test descriptions and referenced dates.
- Follow the listed specimen requirements (e.g., FFPE, plasma) and effective/reference dates when ordering and billing.
Use the 0105U–0111U code excerpt and descriptors for those proprietary tests
Refer to the code excerpt for sample proprietary lab and procedure codes (0105U–0111U) and use those exact codes and descriptors when billing those specific tests.
Bill extended proprietary and specialized test codes as listed
Use the extended proprietary code list when billing the additional specialized tests (e.g., red cell antigen genotyping series and oncology/cardiac panels) shown in the policy.
Use listed oncology genomic profiling U-codes and follow specimen/gene-count notes
Report comprehensive oncology genomic profiling and targeted tumor panels using the oncology U-codes listed in the policy and follow the test descriptors (e.g., gene counts, specimen types).
Bill molecular/genomic tests with the specified U-code listings and specimen notes
Use the policy's molecular/genomic test code listings and descriptions (e.g., 0362U–0364U) for molecular oncology and specialty tests; follow specimen and algorithm notes provided.
Verify and use temporary/new CPT/HCPCS (T/U) codes and effective dates when billing
Follow the additional code entries and activation/effective dates for recently added T/U codes when submitting claims for these services; the policy lists many temporary/new codes with dates.
Bill Category III/T-codes and other temporary codes exactly as listed
Use the policy's temporary and Category III code listings for emerging technologies and procedures; bill using the exact T-code descriptors where applicable.
- Category III examples: 0588T–0590T (neurostimulation system/programming), 0591T–0593T (health coaching), 0599T (fluorescence wound imaging).
- Follow the descriptors and effective dates when reporting these services.
Use 0599T and related fluorescence imaging codes with listed descriptors
Fluorescence wound imaging procedures must be billed with the listed codes (e.g., 0599T) and the policy's descriptor for the imaging session.
- 0599T: real-time fluorescence wound imaging per session; list separately for additional anatomic sites as described.
- Use the effective date and descriptor when documenting and billing.
Bill device implantation/programming/interrogation using the listed CPT/T-codes
Device implantation, programming, and interrogation services must be billed using the listed device and programming codes and follow parameter thresholds where specified.
Report amblyopia remote treatment with 0704T–0705T as listed
Amblyopia remote treatment services must be billed with the listed Category III codes (0704T–0705T) for device supply, set-up, and surveillance services.
Use listed Category III codes for cardiac focal ablation and related procedures
Cardiac focal ablation using radiation therapy and related Category III codes must be billed with the listed T-codes and descriptors.
- Examples: 0745T–0747T for noninvasive arrhythmia localization, treatment planning, and delivery.
- Follow listed effective dates and descriptors when ordering and billing these services.
Bill supplies/devices with the listed HCPCS/C-codes and effective dates
Supply and device HCPCS/C-codes should be used as listed in the policy for device/supply billing; confirm the code descriptor and effective date before submission.
Definitions and Terms
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.